USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Omniscient Neurotechnology Pty Limited

USPTO PatentsView assignee record - 44 granted patents across 10 technology areas, recorded in grant years 2021–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G16H (Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data).

RSS updates for this company

The verdict

According to USPTO PatentsView, Omniscient ranks #7,452 of 49,997 tracked US assignees by granted-patent volume, with 44 patents across 10 technology areas.

#7,452
of 49,997 US assignees by volume
Top 10%
by Innovation Score (52.7/100)
19.4
avg claims per patent

USPTO PatentsView assignee plate

Corpus R7452 · Foreign Corporation #7,452 · 44 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

  • GRANTS-SMALL 44 grants
  • UPPER-Q #7,452/49,997
  • PHOTO-FINISH NovoAmi B V
  • CPC-FOCUS G16H · 10 areas
  • INNOV-PAR 52.7/100
  • CLAIMS-RICH 19.4 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • SPAN-YRS 2021–2025 · 5y
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: NovoAmi B.V. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Omniscient’s 52.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Omniscient

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Omniscient's Innovation Score is 52.7/100 (top 10% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Omniscient?

Each dot is one of Omniscient’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Omniscient’s own 19.4 claims/patent is ABOVE the 14.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Omniscient vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 43.944.044.04444.044.044.1 010203040 Granted patents (volume) Avg claims / patent NovoAmi B.V. - 44, 1Novoami B VNumecent Holdings, Inc. - 44, 17.66Numecent HoldingsOmni United (S) PTE Ltd - 44, 1Omni United (S) P…OTI Lumionics Inc. - 44, 36.32OTI LumionicsPFM Medical GMBH - 44, 14.45PFM MedicalPixia Corp. - 44, 23.32PixiaPrologium Holding Inc. - 44, 15.64Prologium HoldingProtean Electric Limited - 44, 13.09Protean ElectricOmniscient Neurotechnology Pty Limited - 44, 19.45Omniscient Neurot…
Omniscient vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Omniscient's grants concentrate

Omniscient Neurotechnology Pty Limited is a focused PatentsView assignee: 10 CPC subclasses with 79.5% of grants classified under G16H (Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data). Peak complete grant year is 2022 (15 grants) versus a trough of 4 in 2024. By volume, Omniscient sits between NovoAmi B.V. and Protean Electric Limited.

Omniscient's three-year grant acceleration

Omniscient Neurotechnology Pty Limited shows 30 grants in 2022–2024 against only 12 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Omniscient's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Omniscient holds 44 patents at rank #7,453, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Omniscient

By rank, the assignees closest to #7,453 in granted patent volume.

Leaders in G16H (Healthcare Informatics)

Other assignees with the most granted patents in Omniscient's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Omniscient, neither rank-band nor same-CPC leaders (those blocks stay above). In G16H (Healthcare Informatics), Omniscient ranks #133 of 3,149 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (53 here).

Omniscient's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

53 Top 10% higher than 90% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

05101520 20212022202320242025 2
USPTO utility patent grants by year · 2021–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table
Omniscient Neurotechnology Pty Limited patent grants by year, 2015–2025
Year Patents Granted Share of Period
2021 12 27.3%
2022 15 34.1%
2023 11 25.0%
2024 4 9.1%
2025partial year 2 4.5%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Omniscient Neurotechnology Pty Limited's patent record in context - here's where to go next.

  • Omniscient Neurotechnology Pty Limited's lead technology class is G16H (Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data), 79.5% of its portfolio - see every assignee active in that class. Explore G16H
  • Ranked #7,452 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Omniscient Neurotechnology Pty Limited against NovoAmi B.V., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 52.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.